Galvokimig
Based on 1 Customer Validation
Galvokimig (UCB-9741) is an anti-IL-13/IL-17A/albumin (ALB)/IL-17F trispecific Fab-scFv fusion protein. Galvokimig simultaneously binds IL-13 and IL-17 with high affinity and has an extended half-life through albumin binding. Galvokimig inhibits IL-13-mediated, IL-17A-mediated, and IL-17F-mediated signaling. Galvokimig inhibits IL-17A- and IL-17F-induced IL-6 release in dermal fibroblasts and inhibits IL-19 and IL-24 production in primary epidermal keratinocytes. Galvokimig can be used for research on atopic dermatitis.
For research use only. We do not sell to patients.
- Purity : 99.71%
- CAS No.: 2648456-30-6
- Molecular Weight:101.953 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Fab-G1-kappa-[scFv-heavy-kappa]2
Species Reactivity
Human
IC50 & Target
IL13 & IL17A & ALB & IL17F
In Vitro
Galvokimig effectively inhibits IL-13-, IL-17A-, and IL-17F-induced intracellular signalling in HEK-Blue IL-4/IL-13 cells expressing the SEAP reporter gene[1].
Galvokimig inhibits IL-17A- and IL-17F-induced IL-6 release in dermal fibroblasts[1].
Galvokimig suppresses IL-13/IL-17-induced IL-19 and IL-24 production in primary human epidermal keratinocytes[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Gene ID
Accession
Conjugated
Unconjugated
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Fab-G1_kappa-scFv-heavy-kappa
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized IL-13 Protein, Human (HEK293, His, HY-P70568) can bind Galvokimig. The EC50 for this effect is 941.7 ng/mL. -
Immobilized IL-17A Protein, Human (HEK293, His, HY-P70527) can bind Galvokimig. The EC50 for this effect is 31.32 ng/mL. -
Immobilized Serum Albumin/ALB Protein, Human (HEK293, His-Avi, HY-P78393) can bind Galvokimig. The EC50 for this effect is 10.4 ng/mL. -
Immobilized IL-17F Protein, Human (HEK293, His, HY-P70540) can bind Galvokimig. The EC50 for this effect is 595.9 ng/mL.
Chemical Information
-
CAS No. 2648456-30-6
-
Appearance Liquid
-
Molecular Weight 101.953 kDa
-
Color Colorless to light yellow
-
Synonyms
UCB-9741
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (259 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)